Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%

Jul 8, 2025 - 15:00
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%
Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.